This difference between circulating and tumor-associated NK cells was confirmed by principal component analysis (PCA) (Fig. 7b, PC1), as was the accuracy of NK1, NK2 and NK3 annotation at the tumor bed (Fig. 8a,b, PC2 and PC3). The gene discussed is CD160; the disease is neoplasm.